# 18-FLT PET/MR Imaging to Predict Graft Failure and GVHD in Bone Marrow Transplant Patients

> **NCT03546556** · EARLY_PHASE1 · TERMINATED · sponsor: **UNC Lineberger Comprehensive Cancer Center** · enrollment: 10 (actual)

## Conditions studied

- Graft Vs Host Disease

## Interventions

- **DRUG:** Fluorothymidine (FLT)

## Key facts

- **NCT ID:** NCT03546556
- **Lead sponsor:** UNC Lineberger Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-01-01
- **Primary completion:** 2020-03-12
- **Final completion:** 2020-03-12
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Study terminated due to COVID-19 pandemic and not being able to perform PET/MR scans on participants.
- **Last updated:** 2024-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03546556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03546556, "18-FLT PET/MR Imaging to Predict Graft Failure and GVHD in Bone Marrow Transplant Patients". Retrieved via AI Analytics 2026-08-24 from https://api.ai-analytics.org/clinical/NCT03546556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*